Marietta Investment Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Marietta Investment Partners's NVS Position: Q2 2026 in Review
Marietta Investment Partners held its Novartis (NVS) position steady in Q2 2026 at 20,019 shares worth $3.14M. The position accounts for 0.54% of the portfolio, ranked #51.
Marietta Investment Partners first reported a position in NVS in Q4 2014 and has held it in 20 quarters since. 1,449 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Marietta Investment Partners held 20,019 shares of Novartis worth $3.14M as of Q2 2026.
- Marietta Investment Partners left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.54% of Marietta Investment Partners's portfolio in Q2 2026, its #51 holding.
- Marietta Investment Partners first reported a position in Novartis in Q4 2014 and has held it in 20 quarters since.
- 1,449 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Marietta Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.